RK

Ramakrishna K — Q-Sub & Post-market Consultant (Medical Devices)

Deputy Manager - Regulatory Affairs (API)

CMC Regulatory Affairs professional with over 11 years of experience in pharmaceutical regulatory submissions. Specializes in compilation, preparation and submission of Drug Master Files (DMFs) in accordance with filing requirements of Regulatory Authorities including USFDA, EU, EDQM, TGA-Australia, TPD-Canada, WHO, KFDA, Russia, China & ROW countries. Expert in preparation of applicant part DMFs ...

Expertise & Specializations

Regulatory Pathways

Q-SubPost-market

Regions Served

Ramakrishna K provides regulatory consulting services to clients in:

United States (FDA)European Union (MDR/IVDR)Asia-PacificMiddle East & AfricaCanada (Health Canada)Latin America

Executive Summary

Professional Overview

CMC Regulatory Affairs professional with over 11 years of experience in pharmaceutical regulatory submissions. Specializes in compilation, preparation and submission of Drug Master Files (DMFs) in accordance with filing requirements of Regulatory Authorities including USFDA, EU, EDQM, TGA-Australia,...

Core Specializations

Regulatory Pathways

Q-SubPost-market

Services Offered

QMS Setup & Implementation
Quality management system design, implementation, and validation to meet FDA and ISO requirements.
Post-Market Support
Post-market surveillance, adverse event reporting, and ongoing regulatory compliance support.

Cruxi Independent Snapshot

Best suited for

  • • MedTech companies seeking expert regulatory guidance

Experience signals

  • Regions: US, EU, APAC, MEA, CA, LATAM

Cruxi view

With over 11 years of dedicated regulatory experience, Ramakrishna K offers profound expertise in Chemistry, Manufacturing, and Controls (CMC) and Drug Master File (DMF) submissions. While rooted in the pharmaceutical sector, this skillset is uniquely valuable for medtech companies developing combination products, such as drug-eluting stents or pre-filled delivery systems. His extensive track record of successful submissions to a wide array of global authorities—including the USFDA, EU (EDQM), and Health Canada—demonstrates a mastery of complex international regulatory landscapes. This deep knowledge of API regulatory affairs and quality systems, including change control impact analysis, provides a critical and often hard-to-find competency for medtech firms navigating the dual regulatory requirements of device and drug components.

This analysis is generated by Cruxi AI using public information and may not capture the full scope of the consultant's experience.

Contact Ramakrishna K

Share a brief overview of your device and timeline. Cruxi will forward your request to Ramakrishna K and help structure next steps.

Contact Now